The market for laboratory supplies is large and growing. It is also increasingly competitive. We plan to use proprietary technology to substantially increase the productivity of laboratory basesd researchers. This technology platform will provide unique products enabling significant cross-selling, which will confer a major competitive advantage in this high value added market.

Actogen aims to become a market elader in the discovery of novel drugs for the treatment of mental diseases, using its unique high throughput in vivo screening technology.

Development of scientific simulation programmes for astrophysics.

The concept is an intelligent, modular, transportation and sorting system.

CIV will be set up to exploit cutting-edge Computer vision technology that will make the acquisition of 3D models significantly quicker, cheaper and more realsitic than currently possible.

A solution as to how to cool a beverage rapidly, and how to enjoy a cold drink on the go when cooling facilities are not available.

To exploit a unique database of Amazonian medicinal plants to develop novel medicines with an initial focus on women's health needs.

A mobile phone charger that operates using a dynamo mechanism when cycling.

MultiProSys is a Proteomics company positioned as a tools provider in the drug discovery value chain.

No public summary available.